ClinicalTrials.gov
ClinicalTrials.gov Menu

Gender-Responsive Treatment for Women Offenders - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00249613
Recruitment Status : Completed
First Posted : November 7, 2005
Results First Posted : April 7, 2014
Last Update Posted : April 7, 2014
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Michael Prendergast, University of California, Los Angeles

Brief Summary:
The purpose of this study is to determine whether substance abuse treatment designed specifically for drug-dependent women offenders provides better outcomes than standard drug court treatment (mixed-gender programs).

Condition or disease Intervention/treatment Phase
Substance Abuse Problem Behavioral: Women-Only Not Applicable

Detailed Description:
In this five-year study, a total of 300 women entering court-referred treatment throughout Los Angeles County and who agree to participate in the study will be randomly assigned to a women-focused or to a mixed-gender outpatient treatment program. The study will assess the impact of women-focused substance abuse treatment using outcome measures including recidivism, substance abuse and relapse, and social adjustment (e.g., employment, parenting behaviors, psychological improvement, and HIV risk reduction behaviors), compared to the impact of traditional mixed-gender programs. Assessments will occur at baseline and at 1 month, 12 months, and 24 months after admission.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 291 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Gender-Responsive Treatment for Women Offenders
Study Start Date : June 2005
Actual Primary Completion Date : January 2009
Actual Study Completion Date : January 2009

Arm Intervention/treatment
Experimental: Women-Only
Substance abuse treatment program for women only
Behavioral: Women-Only
Gender-responsive treatment for women only
No Intervention: Mixed-Gender
Substance abuse treatment program for both women and men



Primary Outcome Measures :
  1. Results (Unadjusted) for Criminal Activities in Past 30 Days at Baseline and Follow-up for Women in Women-Only Treatment and Mixed-Gender Treatment [ Time Frame: baseline and 1-year follow-up ]
  2. Predictors of Criminal Activity at 12 Months Post Intake [ Time Frame: 12 Months ]
  3. Any Substance Use Past 30 Days [ Time Frame: 12 Months ]
    Substance use in past 30 days at 12 months post intake


Secondary Outcome Measures :
  1. Predictors of Change in Employment at 12 Months Post Intake: Generalized Estimating Equation (GEE) Model [ Time Frame: 12 month post intake ]
    Predictors of change in employment at 12 months post intake: GEE - comparison of Women-Only vs. Mixed-Gender treatment models



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Drug court participant
  • At least eighteen (18) years old
  • Have had no more than three prior non-violent, non-drug felony convictions
  • Do not have a current charge of driving under the influence of alcohol or drugs or a charge of sale or transportation of drugs

Exclusion Criteria:

  • Not capable of giving informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00249613


Locations
United States, California
University of California - Los Angeles
Los Angeles, California, United States, 90024
Sponsors and Collaborators
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Michael Prendergast, Ph.D. University of California, Los Angeles

Publications of Results:
Responsible Party: Michael Prendergast, Research Historian, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT00249613     History of Changes
Other Study ID Numbers: NIDA-16277-1
R01DA016277 ( U.S. NIH Grant/Contract )
First Posted: November 7, 2005    Key Record Dates
Results First Posted: April 7, 2014
Last Update Posted: April 7, 2014
Last Verified: March 2014

Keywords provided by Michael Prendergast, University of California, Los Angeles:
gender-responsive substance abuse treatment

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders